Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Pharmaceutical intelligence for consultancies

Focus on your clients and expand your business opportunities. We’ll help you build a complete picture of the rapidly changing pharmaceutical market with our insight and expertise.

Your trusted pharma partner

With the pharma and healthcare sector facing increasing challenges, your clients rely more than ever on independent intelligence. Pharma Intelligence will help you make smart decisions and stay ahead of a fast changing market.

What we offer

As the trusted partner of the top 50 pharmaceutical companies and 10 contract research organizations, our wide range of solutions cover early phase, clinical R&D, portfolio and strategy, regulatory and commercial planning and analysis.

We cover the life sciences business from drug and device discovery and development to regulatory approval, and drug reimbursement to lifecycle management. And we give you access to past, current and future trends and analysis.

How it helps

Whether you’re working on your next business pitch, engaging on a project for an existing client or working on due diligence for a proposed merger or acquisition; our pharmaceutical intelligence helps you meet the demands of dynamic markets and changing customer needs, with:

Expert analysis of key pharma sectors
In-depth knowledge from drug discovery to market access
Global coverage including digital health, R&D, and emerging markets
Precise analysis and data
Customized reports

Our unique strengths

Understand your clients’ world

Gain a comprehensive understanding of the global pharma market with our complete coverage.

Stay on top of the details

We’ll keep you in touch with complex regulatory and pricing and reimbursement issues.

Think ahead

Respond to market events, identify opportunities and anticipate changes by tracking drug pipelines, patent expiration and commercial activities influencing the landscape.

Deliver tailored solutions

Use our data and insight to create solutions to suit your clients’ needs.

Benefit from a dedicated service

Our services come with dedicated client service and analyst support.

View more
View Less

Relevant products

Thought leadership

Key benefits:

Build brand credibility
Generate Leads
Effective reporting

Awareness

Key benefits:

Direct access to your target Pharma audience
Multi or single channel campaigns
Effective reporting

Lead generation

Key benefits:

Direct access to your target Pharma audience
Multi or single channel campaigns
Measurable results

View all content

Pink Sheet

Getting Worse Not Better: UK Report On Access To Cancer Drugs

05 Dec 2018

A UK report on patient access to cancer drugs suggests that the European Medicines Agency could learn from the US Food and Drug Administration and best practice elsewhere in the world when it comes to taking a faster, more flexible approach to assessing evidence.

Topic Cancer

View article
Scrip

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma

By Jessica Merrill 05 Dec 2018

The billionaire philanthropist and industry agitator took the stage at the Forbes Healthcare Summit to discuss why his foundation is focused on fixing drug pricing and supporting organizations like ICER and Patients for Affordable Drugs.

Topic Drug approval Drug development landscape Drug review

View article
Scrip

Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

By Mandy Jackson 05 Dec 2018

Late-breaker presentations at ASH showed that replacing chemotherapy agents with Imbruvica in CLL, and adding Darzalex to Revlimid and dexamethasone in multiple myeloma, is more effective than current standards of care in certain front-line settings.

Topic Cancer Drug approval

View article
Scrip

AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

By Jung Won Shin 05 Dec 2018

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

Topic Drug development landscape Drug review

View article
Datamonitor Healthcare

Gene Therapy: A Paradigm Shift in Medicine

By Amanda Micklus 30 Nov 2018

The following analysis reviews several aspects of the gene therapy market. The history of gene therapy is briefly discussed, alongside a look at the trend in the volume of candidates in development over the past 20+ years, and how the regulatory landscape in the US and EU has recently adapted to help move the field forward. A deep dive into the pipeline with breakdowns by delivery method and therapy area is provided, as are the key companies involved and the major partnership deals that have made gene therapy a hot commodity. Manufacturing, pricing, and reimbursement issues are also addressed.

Topic Cell and gene therapy

View white paper
Biomedtracker, Datamonitor Healthcare

December 2018 National Influenza Week

29 Nov 2018

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic Influenza virus Infectious diseases

Single report
Datamonitor Healthcare

World AIDS Day 2018 GlaxoSmithKline report

29 Nov 2018

PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

Topic Diseases Drug development landscape Drug review

Single report
Scrip

How Originator Companies Face Up to the Biosimilar Challenge Webinar Recording

By Eleanor Malone 16 Nov 2018

Navigating the issues presented by biosimilars is becoming more complicated. With new barriers facing biosimilar originator companies and threatening to derail development, knowing how to formulate and manage your own biosimilar action plan is critically important.

Topic Biosimilars

Full video
Scrip

Mens Health Drug Developments in Prostate Cancer

06 Nov 2018

November is Men’s Health Awareness Month, and Informa Pharma Intelligence is providing essential insights into drug developments for prostate cancer. Download now for free the "Men's Health: Drug Developments in Prostate Cancer Article Pack", brought to you by Scrip and Pink Sheet.

Topic Drug development landscape

View article
Scrip

Pfizer Well Placed To Lead First Line Advanced RCC Market

By Kevin Grogan 31 Oct 2018

Two successful Phase III studies of Inlyta in combination with two distinct immunotherapies, including its own, Merck KGaA-partnered Bavencio, puts Pfizer in a very strong position in the advanced kidney cancer market.

Topic Cancer

View article
Pink Sheet

Alkermes Depression Drug Faces Tough Questions At US FDA Advisory Committee

By Michael Cipriano 31 Oct 2018

If approved, ALKS 5461 would be first opioid-containing product to carry indication for depression; Alkermes CEO Pops tells Pink Sheet that agency's safety and efficacy concerns are surmountable because "all depression drugs have mixed results."

View article
Scrip

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

By Jessica Merrill 31 Oct 2018

Presiding over his last earnings call as the CEO of Pfizer, Ian Read was pressed about the company's drug pricing strategy for 2019 amid push back from the Trump Administration.

Topic Business strategies

View article
Scrip

Scrip Awards By Numbers 2018 Video

29 Oct 2018

Just how important is it to attend SCRIP Awards 2018? We’ve put together this short video to give you the facts and figures from last year’s awards – can you afford to miss this once-a-year opportunity?

Topic Clinical trials

Full video
Scrip

A timeline of the Takeda/Shire merger

By Mike Ward 26 Oct 2018

A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.

Topic Business strategies Company analysis

View interactive data
Scrip

Induced Pluripotent Stem Cells Help Eisai's Hunt For Novel Parkinson's Leads

By Ian Haydock 26 Oct 2018

As part of broader efforts to pursue novel approaches to common neurological disorders, Eisai uses iPSC-derived cells to help identify potential new drug therapies for Parkinson's.

Topic Parkinsons disease

View article

Latest headlines

Scrip

18 Dec 2018

First Approval For AZ's Roxadustat With China Green Light

Link
Pink Sheet

18 Dec 2018

European CHMP Opinions And MAA Updates

Link
Scrip

18 Dec 2018

VIDEO: Synairgen Developing COPD Treatment To Hold Off Further Viral Damage

Link
Pink Sheet

18 Dec 2018

GDP Failings A Public Health Risk, Says UK Inspector

Link
Pink Sheet

18 Dec 2018

MAH Responsibilities Clarified In Revised EU Guide On Active Substance Master File

Link
Pink Sheet

18 Dec 2018

DTC Price Disclosure Should Include Cost Sharing Context, Patient Groups Tell CMS

Link
Pink Sheet

18 Dec 2018

It’s Time For The Feds To Get Into Drug Manufacturing, Senator Warren Says

Link
Scrip

18 Dec 2018

Executives On The Move: New Hires At EUSA Pharma And Asceneuron, Promotions At Merck And Casma Therapeutics

Link
Pink Sheet

18 Dec 2018

Naloxone Mandate In Opioid Labels Divides US FDA Panel, Even As It Wants Patient Conversations

Link
Scrip

18 Dec 2018

New Company, Big Goal: Serial Entrepreneur Jonathan Lim Launches Erasca To 'Erase Cancer'

Link
Pink Sheet

18 Dec 2018

Time To Spare? US FDA “Opioid-Sparing” Guidance May Take Longer Than Expected

Link
Scrip

18 Dec 2018

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Link
Scrip

17 Dec 2018

BioArctic Outlicenses Alpha-Synuclein Portfolio To AbbVie For Parkinson's

Link
Scrip

17 Dec 2018

Novo Carves Deeper Niche Into CV Market With Staten Dyslipidemia Investment

Link
Scrip

17 Dec 2018

FDA Looks To Strengthen, Speed Drug Reviews With Flow Of Quality Data

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Pharmaceutical intelligence for consultancies

Your trusted pharma partner

Our unique strengths

Understand your clients’ world

Stay on top of the details

Think ahead

Deliver tailored solutions

Benefit from a dedicated service

Relevant products

Below are the Product List

Thought leadership

Awareness

Lead generation

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store